Intravitreal Bevacizumab Versus Triamcinolone Acetonide for Refractory Uveitic Cystoid Macular Edema: A Randomized Pilot Study
- 1 April 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 26 (2), 199-206
- https://doi.org/10.1089/jop.2009.0093
Abstract
Purpose: To compare intravitreal bevacizumab (IVB) versus intravitreal triamcinolone acetonide (IVT) for treatment of refractory uveitic cystoid macular edema (CME). Methods: In this randomized clinical trial, 31 eyes with uveitic CME were allocated into the IVB group—eyes that received 1–3 injections of 1.25 mg bevacizumab (15 eyes) and the IVT group—eyes that received 1–3 injections of 2 mg triamcinolone (16 eyes). Primary outcome measure was change in best-corrected visual acuity (VA) at 36 weeks. Results: Visual acuity improvement compared with baseline values was meaningful in the IVB group at 12, 24, and 36 weeks (−0.35 ± 0.45 logMAR [P = 0.016]) and in the IVT group at 24 and 36 weeks (−0.32 ± 0.32 logMAR [P = 0.001]). A significant central macular thickness (CMT) reduction was observed only in the IVT group at week 36 (74.6 ± 108.0 μm [P = 0.049]). Between-group analysis disclosed no significant difference in any outcome measure. By statistically removing the factor of cataract, the IVT group had more improvement in VA (P = 0.007). Conclusions: IVB was as effective as IVT in refractory uveitic CME regarding VA improvement up to 36 weeks. Irrespective of triamcinolone-induced cataract, a more beneficial effect of IVT may be attainable.Keywords
This publication has 22 references indexed in Scilit:
- Short-term Safety and Efficacy of Intravitreal Triamcinolone Acetonide for Uveitic Macular Edema in ChildrenAmerican Journal of Ophthalmology, 2008
- Inflammatory cystoid macular edemaCurrent Opinion in Opthalmology, 2007
- Intravitreal Bevacizumab for Treatment of Uveitic Macular EdemaOphthalmology, 2007
- Impact of Macular Edema on Visual Acuity in UveitisOphthalmology, 2006
- Outcome of Intravitreal Triamcinolone in UveitisOphthalmology, 2005
- Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcomeActa Ophthalmologica Scandinavica, 2005
- Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edemaAmerican Journal of Ophthalmology, 2001
- Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography studyOphthalmology, 2001
- Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitisClinical & Experimental Ophthalmology, 2001
- Causes and frequency of blindness in patients with intraocular inflammatory disease.British Journal of Ophthalmology, 1996